Any product protected by a patent in the territory of a Member State and subject, prior to being placed on the market as a medicinal product, to an administrative authorization procedure as laid down in Council Directive 65/65/EECf1 or Directive 81/851/EECf2 may, under the terms and conditions provided for in this Regulation, be the subject of a certificate.
Annotations
Footnotes
- f1
-
OJ No. L22, 9.12.1965, page 369. Last amended by Directive 89/341/EEC (OJ No. L142, 25.5.1989, p. 11).
- f2
-
OJ No. L317, 6.11.1981, p. 1. Amended by Directive 90/676/EEC (OJ No. L373, 31.12.1990, p. 15).
Notes on Part 1
Footnotes
- f1
-
OJ No. C114, 8.5.1990, p. 10.
- f2
-
OJ No. C19, 28.1.1991, p. 94 and OJ No. C150, 15.6.1992.
- f3
-
OJ No. C69, 18.3.1991, p. 22.